Related Experiment Video
Updated: Oct 26, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Preventing type 1 diabetes in childhood
Colin M Dayan1,2, Rachel E J Besser3, Richard A Oram4
1Wellcome Centre for Human Genetics, Nuffield Department of Medicine, National Institute for Health Research (NIHR) Biomedical Research Centre, University of Oxford, Oxford, UK. dayancm@cardiff.ac.uk.
Early detection of type 1 diabetes (T1D) through autoantibody and genetic screening can identify at-risk children. This allows for interventions to preserve insulin-producing cells, potentially eliminating the need for daily insulin injections.
Area of Science:
- Immunology
- Endocrinology
- Pediatrics
Background:
- Type 1 diabetes (T1D) is an autoimmune condition where pancreatic beta cells are destroyed by T lymphocytes.
- Current management focuses on insulin replacement after diagnosis.
Purpose of the Study:
- To shift T1D management towards early diagnosis and beta cell preservation.
- To explore the potential for preventing or delaying the need for insulin therapy in children.
Main Methods:
- Monitoring of pancreatic islet autoantibodies.
- Genetic risk assessment in children.
- Evaluating immunotherapy for secondary prevention of T1D progression.
- Assessing primary prevention strategies targeting the autoimmune process.
Main Results:
- Identification of most children at risk for T1D before significant beta cell loss.
- Successful secondary prevention trials delaying disease progression.
- Primary prevention trials have entered large-scale clinical studies.
Conclusions:
- Early diagnosis and beta cell preservation are key to altering T1D management.
- A future free from daily insulin injections for children with T1D is anticipated.
- Proactive strategies can prevent autoimmune destruction of pancreatic beta cells.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

